Free Trial
NASDAQ:SWTX

SpringWorks Therapeutics (SWTX) Stock Price, News & Analysis

SpringWorks Therapeutics logo
$46.99 0.00 (0.00%)
As of 07/1/2025

About SpringWorks Therapeutics Stock (NASDAQ:SWTX)

Key Stats

Today's Range
$46.99
$46.99
50-Day Range
$46.08
$46.99
52-Week Range
$28.21
$62.00
Volume
N/A
Average Volume
2.57 million shs
Market Capitalization
$3.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.57
Consensus Rating
Hold

Company Overview

SpringWorks Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

SWTX MarketRank™: 

SpringWorks Therapeutics scored higher than 28% of companies evaluated by MarketBeat, and ranked 779th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SpringWorks Therapeutics has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 1 buy rating, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    SpringWorks Therapeutics has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about SpringWorks Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for SpringWorks Therapeutics are expected to grow in the coming year, from ($2.05) to ($0.13) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SpringWorks Therapeutics is -13.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SpringWorks Therapeutics is -13.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SpringWorks Therapeutics has a P/B Ratio of 7.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about SpringWorks Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    9.19% of the float of SpringWorks Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    SpringWorks Therapeutics has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SpringWorks Therapeutics has recently increased by 2.24%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    SpringWorks Therapeutics does not currently pay a dividend.

  • Dividend Growth

    SpringWorks Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.19% of the float of SpringWorks Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    SpringWorks Therapeutics has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SpringWorks Therapeutics has recently increased by 2.24%, indicating that investor sentiment is decreasing.
  • News Sentiment

    SpringWorks Therapeutics has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for SpringWorks Therapeutics this week, compared to 7 articles on an average week.
Receive SWTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SWTX Stock News Headlines

Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

SWTX Stock Analysis - Frequently Asked Questions

SpringWorks Therapeutics' stock was trading at $36.13 at the start of the year. Since then, SWTX shares have increased by 30.1% and is now trading at $46.99.

SpringWorks Therapeutics (NASDAQ:SWTX) released its earnings results on Friday, May, 9th. The company reported ($1.11) EPS for the quarter, missing the consensus estimate of ($0.81) by $0.30. The business earned $49.09 million during the quarter, compared to analysts' expectations of $64.19 million. SpringWorks Therapeutics had a negative net margin of 115.60% and a negative trailing twelve-month return on equity of 51.10%.

SpringWorks Therapeutics subsidiaries include these companies: SpringWorks Subsidiary 1 Inc, SpringWorks Subsidiary 2 Inc, SpringWorks Subsidiary 3 Inc, SpringWorks Subsidiary 4 Inc, SpringWorks Therapeutics LLC, and SpringWorks Therapeutics Operating Company Inc..

SpringWorks Therapeutics (SWTX) raised $126 million in an initial public offering (IPO) on Friday, September 13th 2019. The company issued 7,400,000 shares at $16.00-$18.00 per share. ​J.P. Morgan, Goldman Sachs and Cowen​ ​ served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Shares of SWTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SpringWorks Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
5/09/2025
Today
7/05/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SWTX
Fax
N/A
Employees
230
Year Founded
2017

Price Target and Rating

Average Stock Price Target
$52.57
High Stock Price Target
$68.00
Low Stock Price Target
$47.00
Potential Upside/Downside
+11.9%
Consensus Rating
Hold
Rating Score (0-4)
2.13
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$258.13 million
Net Margins
-115.60%
Pretax Margin
-115.60%

Debt

Sales & Book Value

Annual Sales
$191.59 million
Price / Cash Flow
N/A
Book Value
$6.47 per share
Price / Book
7.26

Miscellaneous

Free Float
69,449,000
Market Cap
$3.54 billion
Optionable
Optionable
Beta
0.68

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:SWTX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners